Thursday May 25th 2017

Archive for January, 2014

The use of complementary and alternative medicine in patients with multiple sclerosis: A longitudinal study.

The use of complementary and alternative medicine in patients with multiple sclerosis: A longitudinal study.

This study captured the using of CAM of MS patients in combination with disease progression. METHODS: 119 Patients with MS were asked about CAM utilization, sociodemographic and disease factors within the context of a semistructured interview at an interval of seven years. [Read More]

Differentiating white matter lesions in multiple sclerosis and migraine using monoexponential and biexponential diffusion measurements

Differentiating white matter lesions in multiple sclerosis and migraine using monoexponential and biexponential diffusion measurements

ConclusionBiexponential diffusion analysis may help to differentiate multiple sclerosis‐related white matter lesions from migraine‐related ones.J. Magn. Reson. Imaging 2014. © 2014 Wiley Periodicals, Inc. (Source: Journal of Magnetic Resonance Imaging) [Read More]

[Collaborative networks between Spain and Latin America regarding multiple sclerosis].

[Collaborative networks between Spain and Latin America regarding multiple sclerosis].

Authors: Dorta-Contreras AJ, Fundora-Mirabal JA PMID: 24469943 (Source: Revista de Neurologia)MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here. [Read More]

 Page 1 of 118  1  2  3  4  5 » ...  Last » 

Latest Topics

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Hospitals vary widely in how often they transition people with strokes from active treatment to comfort or hospice care [Read More]

Roche investigating case of patient illness after taking MS drug

Roche investigating case of patient illness after taking MS drug

ZURICH (Reuters) - A person in Germany treated with Roche ’s new multiple sclerosis drug Ocrevus has been diagnosed [Read More]

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]